No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
LNTH240517C55000
- 21.00
- 0.000.00%
15min DelayTrading May 2 09:31 ET
0.00High0.00Low
0.00Open21.00Pre Close0 Volume25 Open Interest55.00Strike Price0.00Turnover0.00%IV-0.07%PremiumMay 17, 2024Expiry Date21.00Intrinsic Value100Multiplier7DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma3.63Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
Lantheus Holdings, Inc. (NASDAQ:LNTH) Q1 2024 Earnings Call Transcript
Lantheus (LNTH) Q1 Earnings Surpass Estimates, Gross Margin Up
Evaluating Lantheus Holdings: Insights From 5 Financial Analysts
Lantheus Holdings (NASDAQ:LNTH) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.The following table encapsulates their recent ratings,
Truist Raises Lantheus Holdings' PT to $94 From $82 After 'Solid' Q1 Beat, Keeps Buy Rating
Lantheus Holdings (LNTH) has an average rating of buy and price targets ranging from $83 to $128, according to analysts polled by Capital IQ. Price: 78.18, Change: +10.79, Percent Change: +16.01
Strong Buy Rating for Lantheus Holdings Amidst Robust Financials and Growth Prospects
Lantheus Holdings Is Maintained at Buy by Mizuho
Lantheus Holdings Is Maintained at Buy by Mizuho
Comments
$Lantheus(LNTH.US$ let’s go baby!
Last week’s PDUFAs:
$BeiGene(BGNE.US$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb(BMY.US$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals(VNDA.US$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia(EYEN.US$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
$BeiGene(BGNE.US$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb(BMY.US$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals(VNDA.US$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia(EYEN.US$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
20
2
Paul Blanchfield, Lantheus' President, is confident in Morgan's ability to guide the company's commercial activities and generate value. Morgan is excited about her new role and the opportunity to advance Lantheus' diverse portfolio.
1
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after market closed (gaps range from large to small):
Gap Ups
1. $Clorox(CLX.US$ - up 4.6%
2. $Cognizant(CTSH.US$ - up 4.1%
3. $Informatica(INFA.US$ - up 2.8%
4. $Kanzhun(BZ.US$ - up 2.7%
5. $Sunrun(RUN.US$ - up 2.6%
6. $Regeneron Pharmaceuticals(REGN.US$ - up 1.9%
7. $McKesson(MCK.US$ - up 1.9%
8. $Curtiss-Wright(CW.US$ - up 1.7%
9. $MercadoLibre(MELI.US$ - up 1.5...
Gap Ups
1. $Clorox(CLX.US$ - up 4.6%
2. $Cognizant(CTSH.US$ - up 4.1%
3. $Informatica(INFA.US$ - up 2.8%
4. $Kanzhun(BZ.US$ - up 2.7%
5. $Sunrun(RUN.US$ - up 2.6%
6. $Regeneron Pharmaceuticals(REGN.US$ - up 1.9%
7. $McKesson(MCK.US$ - up 1.9%
8. $Curtiss-Wright(CW.US$ - up 1.7%
9. $MercadoLibre(MELI.US$ - up 1.5...
+16
21
Here are the top gap ups and downs for the stocks with a market cap above $5 billion after the previous market closed (gaps range from large to small):
Gap Ups
1. $Shopify(SHOP.US$ - up 12.4%
2. $Ball Corp(BALL.US$ - up 5.6%
3. $SolarEdge Technologies(SEDG.US$ - up 4.2%
4. $Datadog(DDOG.US$ - up 4.1%
5. $Fleetcor Technologies(FLT.US$ - up 3.5%
6. $Cognizant(CTSH.US$ - up 3.3%
7. $AngloGold Ashanti(AU.US$ - up 3.0%
8. $Lantheus(LNTH.US$ - up 2.9...
Gap Ups
1. $Shopify(SHOP.US$ - up 12.4%
2. $Ball Corp(BALL.US$ - up 5.6%
3. $SolarEdge Technologies(SEDG.US$ - up 4.2%
4. $Datadog(DDOG.US$ - up 4.1%
5. $Fleetcor Technologies(FLT.US$ - up 3.5%
6. $Cognizant(CTSH.US$ - up 3.3%
7. $AngloGold Ashanti(AU.US$ - up 3.0%
8. $Lantheus(LNTH.US$ - up 2.9...
+17
10
Read more